Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ ARID4A Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA132488
Description
Recommended positive controls: HepG2. Predicted reactivity: Cow: 86%; Dog: 100%; Guinea Pig: 79%; Horse: 100%; Mouse: 92%; Pig: 86%; Rabbit: 86%; Rat: 93%.
ARID4A encodes a ubiquitously expressed nuclear protein. It binds directly, with several other proteins, to retinoblastoma protein (pRB) which regulates cell proliferation. pRB represses transcription by recruiting the encoded protein. This protein, in turn, serves as a bridging molecule to recruit HDACs and, in addition, provides a second HDAC-independent repression function. The encoded protein possesses transcriptional repression activity. Multiple alternatively spliced transcripts have been observed for this gene, although not all transcript variants have been fully described.
Specifications
ARID4A | |
Polyclonal | |
Unconjugated | |
ARID4A | |
A630009N03; A630067N03Rik; ARID domain-containing protein 4A; ARID4A; AT rich interactive domain 4A (Rbp1 like); AT rich interactive domain 4A (RBP1-like); AT-rich interaction domain 4A; AT-rich interactive domain-containing protein 4A; MmRBBP1; Rbbp1; RBBP-1; RBP1; RBP-1; retinoblastoma binding protein 1; retinoblastoma-binding protein 1 | |
Rabbit | |
Protein A | |
RUO | |
5926 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Western Blot | |
2 mg/mL | |
PBS with 2% sucrose and 0.09% sodium azide | |
P29374 | |
ARID4A | |
Synthetic peptide derived from a region between residues 1119 - 1168 of human Retinoblastoma binding protein 1. | |
100 μg | |
Primary | |
Human | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction